Skip to main content
. 2022 Apr 26;13:867627. doi: 10.3389/fgene.2022.867627

FIGURE 13.

FIGURE 13

Drug sensitivity in different risk groups and potential targeted drugs. AKT inhibitors (A), mitomycin (B), rapamycin (C), sorafenib (D), and targeted drugs (E).